Abstract
Eighty-one first-time normal donors underwent leukapheresis for peripheral blood progenitor cell (PBPC) collection after mobilization with filgrastim administered either twice-daily (6 μg/kg every 12 h: n = 40) or once-daily (12 μg/kg: n = 41) subcutaneously for 3 d. The groups were similar for age, donor blood volume and target CD34+ cell dose to be collected (≤ 4 x 106 CD34+ cells/kg recipient). There was no statistically significant difference in the apheresis yield of CD34+ PBPCs (x 106) per kg recipient weight (5·6 ± 3·3 vs. 5·6 ± 4·3: P = 0·94) and per litre of blood processed (30± 17·2 vs. 30·4 ± 19·5: P = 0·92).
| Original language | English |
|---|---|
| Pages (from-to) | 770-772 |
| Number of pages | 3 |
| Journal | British Journal of Haematology |
| Volume | 109 |
| Issue number | 4 |
| DOIs | |
| State | Published - 2000 |
Keywords
- Filgrastim
- Granulocyte colony- stimulating factor
- Leukapheresis
- Normal donors
- Peripheral blood progenitor cell mobilization
Fingerprint
Dive into the research topics of 'A comparative study of once-daily versus twice-daily filgrastim administration for the mobilization and collection of CD34+ peripheral blood progenitor cells in normal donors'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver